Stockscreener 앱 받기
18.83
1.47%
-0.28
시간 외 거래:
19.00
0.17
+0.90%
Adma Biologics Inc 주식(ADMA)의 최신 뉴스
ADMA STOCK NEWS: ADMA Biologics is Under Investigation for Securities Fraud after Stock Dropped 20%; Contact BFA Law if You Suffered Losses (Nasdaq:ADMA) - AccessWire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against ADMA Biologics, Inc. (ADMA) - Business Wire
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q3 Earnings? - Yahoo Finance
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
Vanguard Group Inc's Strategic Acquisition in ADMA Biologics Inc - GuruFocus.com
Did ADMA Biologics Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Securities Fraud Investigation (Nasdaq:ADMA) - AccessWire
ADMA Biologics, Inc. (NASDAQ:ADMA) Holdings Increased by Roman Butler Fullerton & Co. - MarketBeat
ADMA Biologics jumps as KPMG becomes new auditor - MSN
ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting Debacle - MSN
BFA Law is Investigating ADMA BIOLOGICS for Securities - GlobeNewswire
BFA Law is Investigating ADMA BIOLOGICS for Securities Fraud after Stock Plummets 20%; Contact the Firm if You Suffered Losses (Nasdaq:ADMA) - GlobeNewswire Inc.
ADMA Biologics stock jumps after naming auditor (ADMA:NASDAQ) - Seeking Alpha
ADMA Biologics (NASDAQ:ADMA) Shares Gap UpTime to Buy? - MarketBeat
ADMA INVESTIGATION NOTE: Contact BFA Law about ADMA Biologics Securities Fraud Investigation into Auditor Resignation (Nasdaq:ADMA) - AccessWire
Rice Hall James & Associates LLC Cuts Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics appoints KPMG as new auditor - Investing.com India
ADMA Biologics (ADMA) to Release Quarterly Earnings on Thursday - MarketBeat
Short Interest in ADMA Biologics, Inc. (NASDAQ:ADMA) Declines By 5.9% - MarketBeat
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - Zacks Investment Research
Louisiana State Employees Retirement System Makes New $2.25 Million Investment in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewswire
ADMA INVESTIGATION NOTICE: ADMA Biologics Stock Plummets - GlobeNewswire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics Inc (ADMA) Shareholders to Inquire about Securities Investigation - AccessWire
ADMA FRAUD ALERT: BFA Law Notifies ADMA Biologics Investors - GlobeNewswire
PFG Investments LLC Has $4.42 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Trading (ADMA) With Integrated Risk Controls - Stock Traders Daily
Assenagon Asset Management S.A. Raises Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA INVESTOR ALERT: ADMA Biologics Investors that Suffered Losses are Alerted to Contact BFA Law about Securities Fraud Investigation into Auditor Resignation (Nasdaq:ADMA) - AccessWire
Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics Inc (ADMA) Stockholders to Inquire about Securities Investigation - AccessWire
Bragar Eagel & Squire, P.C. Is Investigating ADMA - GlobeNewswire
Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics Inc (ADMA) Investors to Inquire about Securities Investigation - AccessWire
ADMA INVESTIGATION UPDATE: ADMA Biologics Investors are - GlobeNewswire
ADMA INVESTIGATION NOTICE: ADMA Biologics, Inc. Investors are Alerted of Ongoing Securities Fraud Investigation after Stock Drops 20%; Contact BFA Law for Information - AccessWire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire
ADMA FRAUD UPDATE: ADMA Biologics, Inc. Investors are Notified to Contact BFA Law about the Securities Fraud Investigation after Auditor Resignation (Nasdaq:ADMA) - AccessWire
State Street Corp's Strategic Acquisition of ADMA Biologics Shares - Yahoo Finance
State Street Corp's Strategic Acquisition of ADMA Biologics Shar - GuruFocus.com
ADMA Biologics ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses - GlobeNewswire
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm - Kilgore News Herald
ADMA FRAUD ALERT: BFA Law Alerts ADMA Biologics, Inc. Investors to Contact the Firm about its Investigation into the Company after Auditor Resigns - AccessWire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics Inc (ADMA) And Encourages Investors to Reach Out - AccessWire
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on - The Bakersfield Californian
ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
(ADMA) Long Term Investment Analysis - Stock Traders Daily
ADMA Biologics Stock Skyrockets 262.1% YTD: How to Play the Stock? - MSN
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc - EIN News
Why I'm Expecting a Price Bounce Back for ADMA - TheStreet
ADMA LEGAL NOTICE: ADMA Biologics, Inc. is being - GlobeNewswire
ADMA Biologics shares maintain buy rating despite auditor change By Investing.com - Investing.com Canada
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? - Yahoo Finance
Key Takeaways From ADMA Biologics Analyst Ratings - Benzinga
Zacks.com featured highlights include Atour Lifestyle, Vertiv, Corcept Therapeutics, Qifu Technology and ADMA Biologics - Zacks Investment Research
Inspire Investing LLC Raises Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
ADMA SHAREHOLDER ALERT: ADMA Biologics, Inc. is Under - GlobeNewswire
2.02%
0.47%
자본화:
|
볼륨(24시간):